
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.240 | 1.240 | 0.000 |
Shares | 98.760 | 98.760 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.290 | 14.965 |
Price to Book | 2.809 | 1.978 |
Price to Sales | 1.605 | 1.150 |
Price to Cash Flow | 16.077 | 9.233 |
Dividend Yield | 1.493 | 2.566 |
5 Years Earnings Growth | 8.213 | 11.212 |
Name | Net % | Category Average |
---|---|---|
Technology | 30.060 | 18.189 |
Healthcare | 22.260 | 12.204 |
Industrials | 19.160 | 25.411 |
Financial Services | 12.590 | 12.315 |
Consumer Cyclical | 7.440 | 14.116 |
Basic Materials | 4.570 | 7.006 |
Consumer Defensive | 2.640 | 4.857 |
Communication Services | 1.280 | 5.331 |
Number of long holdings: 65
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Boku | USU7744C1063 | 3.83 | 205.00 | -2.38% | |
Alpha FX | GB00BF1TM596 | 3.73 | 3,100.00 | -2.36% | |
Robertet | FR0000039091 | 2.90 | 816.00 | +1.37% | |
Uniphar | IE00BJ5FQX74 | 2.89 | 3.66 | -0.27% | |
JTC PLC | JE00BF4X3P53 | 2.87 | 821.00 | -2.96% | |
Niox PLC | GB00BJVD3B28 | 2.66 | 67.80 | -0.29% | |
Teqnion | SE0012308088 | 2.65 | 151.8000 | +1.20% | |
JDC Group | DE000A0B9N37 | 2.51 | 23.80 | 0.00% | |
Pharmanutra | IT0005274094 | 2.36 | 46.30 | -1.17% | |
Dermapharm | DE000A2GS5D8 | 2.13 | 35.00 | -0.28% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Inv SICAV Euro I | 59.01M | 9.06 | 8.37 | 5.54 | ||
Danske Invest S Europe High Dividea | 61.59M | 17.25 | 9.95 | 5.26 | ||
Danske Invest S Europe High Dividee | 61.44M | 17.52 | 10.87 | 6.14 | ||
Danske Inv SICAV Euro SCap I | 31.73M | 1.91 | 0.71 | 5.97 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review